Evidence map›Paper›PMID 42649570›Full record

ArticleCell biochemistry and function2026

Integrated RNA Sequencing and Multi-Bioinformatics Analyses Reveal the Molecular Mechanisms Underlying the Anti-Breast Cancer Effects of the Fritillariae Thunbergii Bulbus-Bolbostemmatis Rhizoma Herb Pair.

Quan Tang, Dong Niu, He Li, Heng Zhou Zhu, Chun Hui Jin, Guo Qing Zhao, Xiao Dan Zhu

Abstract read
In one paragraph

Article in Cell biochemistry and function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Quan TangDepartment of Oncology, Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, P.R. China.ORCID https://orcid.org/0009-0009-9413-2701
Dong NiuDepartment of Oncology, Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, P.R. China.ORCID https://orcid.org/0000-0003-1488-4161
He LiDepartment of Oncology, Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, P.R. China.
Heng Zhou ZhuDepartment of Oncology, Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, P.R. China.ORCID https://orcid.org/0009-0008-0142-0759
Chun Hui JinDepartment of Oncology, Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, P.R. China.ORCID https://orcid.org/0000-0002-8795-9542
Guo Qing ZhaoOffice of Academic Research, Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, P.R. China.
Xiao Dan ZhuDepartment of Oncology, Nanjing University of Chinese Medicine Wuxi Affiliated Hospital: Wuxi Hospital of Traditional Chinese Medicine, Wuxi, P.R. China.

Funding

National Natural Science Foundation of China 82274269Natural Science Foundation of Nanjing University of Chinese Medicine XZR2023095Project supported by the Natural Science Foundation of Jiangsu Province, China BK20240309Top Talent Support Program for young and middle-aged people of Wuxi Health Committee HB2023067
6 · The paper itself

Abstract

Breast cancer (BC) is a highly heterogeneous malignancy with complex molecular mechanisms, highlighting the need for effective biomarkers and therapeutic targets. The Fritillariae Thunbergii Bulbus-Bolbostemmatis Rhizoma (ZBM-TBM) herb pair has been used in the treatment of BC, although its potential molecular mechanisms remain incompletely understood. In this study, an integrated strategy combining transcriptomic analysis, machine learning, liquid chromatography-tandem mass spectrometry (LC-MS/MS), network pharmacology, molecular docking, molecular dynamics (MD) simulations, and single-cell virtual knockout analysis was employed to identify BC-associated molecular biomarkers and explore the potential mechanisms underlying the effects of ZBM-TBM. Integration of weighted gene co-expression network analysis with least absolute shrinkage and selection operator regression, random forest, and support vector machine-recursive feature elimination identified EPCAM as the only common core gene. EPCAM was significantly upregulated in BC tissues and showed favorable diagnostic performance (AUC = 0.903), while high EPCAM expression was associated with shorter overall survival (log-rank P = 0.032). Functional analyses indicated that EPCAM was associated with tumor-related and immune-related biological processes, including cell cycle regulation, DNA replication, and immune regulation. LC-MS/MS analysis identified 32 major active constituents of ZBM-TBM, and subsequent network pharmacology analysis identified 33 overlapping targets and 10 hub genes enriched in multiple tumor- and immune-related signaling pathways, including the Notch, IL-17, HIF-1, and TGF-β signaling pathways. Although ZBM-TBM did not directly target EPCAM in the predicted target network, computational analyses indicated functional associations between EPCAM and hub gene-associated regulatory networks. Molecular docking and MD simulations further suggested that peiminine may represent a potential active constituent, exhibiting favorable predicted binding characteristics with multiple candidate targets, particularly AURKA. Single-cell virtual knockout analysis showed that computational perturbation of AURKA was associated with alterations in cell cycle-, extracellular matrix-, and cell adhesion-related processes, supporting its potential functional relevance at the cellular level.

Indexed as

Antineoplastic Agents, PhytogenicBreast NeoplasmsComputational BiologyDrugs, Chinese HerbalFritillariaSequence Analysis, RNACevanesFemaleHumansMolecular Docking SimulationMolecular Dynamics SimulationRhizomeTandem Mass SpectrometryAntineoplastic Agents, PhytogenicCevanesDrugs, Chinese Herbalpeimininebioinformaticsbreast cancerEPCAMFritillariae Thunbergii Bulbus–Bolbostemmatis Rhizomamachine learning

Identifiers

PMID42649570
PMCPMC13519054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.